J B CHEMICALS AND PHARMA (JBCHEPHARM)

NSE: ₹2,133.70
BSE: ₹2,131.65
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Change in Management

Change in Senior Management Personnel

2026-06-12 18:08:24
Letter To Shareholders - Integrated Annual Report 2025-26

Letter to shareholders - Integrated Annual Report 2025-26

2026-05-27 18:31:54
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement

2026-05-26 20:34:57
Business Responsibility and Sustainability Reporting (BRSR)

BRSR for FY 26

2026-05-25 17:22:29
Reg. 34 (1) Annual Report.

Annual Report for FY 26

2026-05-25 17:19:56
Intimation Of Notice Of AGM To Be Held On June 17, 2026

Intimation of Notice of AGM to be held on June 17, 2026

2026-05-25 17:05:53
Compliances-Reg.24(A)-Annual Secretarial Compliance

Disclosure of Annual Secretarial Compliance Certificate for the financial year ended March 31, 2026

2026-05-22 17:46:40
Intimation Of Record Date

Intimation of Record Date

2026-05-21 18:24:52
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication

2026-05-20 18:48:18
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Transcript

2026-05-13 14:20:06

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 896.20 881.74 844.51 861.73 1,004.40 1,000.62 963.49 949.48 1,093.94 1,084.90 1,064.72 904.23
YOY Revenue Growth % 14.19% 8.93% 6.53% 13.04% 12.07% 13.48% 14.09% 10.18% 8.91% 8.42% 10.51% -4.77%
Other Income 5.63 7.66 7.35 16.63 5.89 9.95 8.00 14.48 14.55 15.34 18.28 11.98
Total Income 901.83 889.40 851.86 878.36 1,010.29 1,010.57 971.49 963.96 1,108.49 1,100.24 1,083.00 916.21
Total Expenses + 707.53 680.74 667.91 713.76 770.45 774.04 753.50 770.93 836.88 821.09 816.13 754.34
Cost of Materials Consumed 218.81 221.35 198.94 177.18 251.63 179.20 200.23 188.97 241.38 225.34 212.01 233.71
Employee Benefit Expense 148.75 148.28 151.68 152.70 166.91 170.57 173.31 176.82 194.29 188.26 191.42 198.73
Other Expenses 205.37 191.75 196.08 210.63 217.37 221.11 218.93 224.58 251.68 241.55 248.05 230.12
Operating Profit 188.67 201.00 176.60 147.97 233.95 226.58 209.99 178.55 257.06 263.81 248.59 149.89
OPM % 21.1% 22.8% 20.9% 17.2% 23.3% 22.6% 21.8% 18.8% 23.5% 24.3% 23.3% 16.6%
Profit Before Tax + 194.30 208.66 183.95 164.60 239.84 236.53 217.99 193.03 271.61 279.15 266.87 134.69
Tax Expense 51.98 58.07 50.38 38.44 63.01 61.96 55.50 47.34 69.23 71.33 68.98 33.32
Tax % 26.8% 27.8% 27.4% 23.4% 26.3% 26.2% 25.5% 24.5% 25.5% 25.6% 25.8% 24.7%
Profit After Tax 142.32 150.59 133.57 126.16 176.83 174.57 162.49 145.69 202.38 207.82 197.89 101.37
EPS (Basic) 18.39 9.72 8.62 8.22 11.39 11.24 10.46 9.36 12.99 13.29 12.63 6.35

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 4,147.79 3,917.99 3,484.18 3,149.28 2,424.24 2,042.52 1,774.73
YOY Revenue Growth % 5.87% 12.45% 10.63% 29.91% 18.69% 15.09% -
Other Income 60.15 38.32 37.27 9.94 39.23 112.38 50.67
Total Income 4,207.94 3,956.31 3,521.45 3,159.22 2,463.47 2,154.90 1,825.40
Total Expenses + 3,228.43 3,068.92 2,769.94 2,603.99 1,958.57 1,558.02 1,218.84
Cost of Materials Consumed 912.44 820.03 816.28 783.98 602.22 542.39 452.48
Employee Benefit Expense 772.70 687.61 601.41 543.45 439.24 340.60 322.92
Other Expenses 971.39 881.99 803.83 741.88 598.61 440.01 443.44
Operating Profit 919.36 849.07 714.24 545.29 465.68 484.50 555.89
OPM % 22.2% 21.7% 20.5% 17.3% 19.2% 23.7% 31.3%
Profit Before Exceptional 979.51 887.39 751.51 555.23 504.90 596.89 358.89
Exceptional Items -27.18 0.00 0.00 0.00 0.00 0.00 -10.00
Profit Before Tax + 952.33 887.39 751.51 555.23 504.90 596.89 348.89
Tax Expense 242.86 227.81 198.88 145.23 118.86 148.36 76.50
Tax % 25.5% 25.7% 26.5% 26.2% 23.5% 24.9% 21.9%
Profit After Tax 709.47 659.58 552.63 410.00 386.04 448.52 272.39
EPS (Basic) 45.16 42.45 35.66 53.00 49.86 57.96 34.20

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 2,022.62 2,339.32 2,125.79 1,999.11 1,332.55 685.51 0.00
Property, Plant & Equipment 611.63 609.94 571.56 532.01 519.47 544.09 0.00
Capital Work in Progress 61.16 46.70 63.32 44.41 13.91 25.57 0.00
Non-Current Investments 26.03 27.98 23.71 13.78 12.72 12.91 0.00
Goodwill 57.46 57.46 57.46 57.46 57.46 57.46 0.00
Other Intangible Assets 1,216.34 1,300.79 1,375.38 1,311.54 700.06 32.11 0.00
Current Assets + 2,946.03 1,934.46 1,868.34 1,554.76 1,274.86 1,552.60 0.00
Inventories 683.40 528.95 502.51 430.49 409.96 347.45 0.00
Trade Receivables 780.91 815.38 686.92 575.80 555.69 389.02 0.00
Cash and Cash Equivalents 110.18 115.09 88.22 76.93 56.54 28.69 0.00
Current Investments 738.91 317.11 364.65 192.18 0.00 664.97 0.00
LIABILITIES & EQUITY
Total Equity 4,159.22 3,433.32 2,923.33 2,480.35 2,138.61 1,813.43 0.00
Equity Share Capital 16.06 15.57 15.52 15.48 15.46 15.46 0.00
Other Equity 4,143.16 3,417.75 2,907.81 2,464.87 2,118.67 1,794.27 0.00
Non-Current Liabilities 218.25 208.13 202.57 519.07 85.07 79.41 0.00
Current Liabilities 591.18 632.33 868.23 554.45 383.72 345.27 0.00
Total Liabilities 809.43 840.46 1,070.80 1,073.52 468.79 424.69 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 703.93 902.45 800.62 625.61 170.13 314.78 0.00
Cash from Investing Activities -585.88 -295.89 -403.83 -961.79 2.32 -230.68 0.00
Cash from Financing Activities -123.11 -579.68 -385.48 356.54 -138.38 87.42 0.00
Net Increase/Decrease in Cash -4.91 26.87 11.29 20.39 34.07 171.53 0.00